Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia
- 1 June 1986
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 73 (2), 157-163
- https://doi.org/10.1007/bf00291607
Abstract
A variant of apolipoprotein E, denoted apo E3-Leiden, has been identified in a 41-year-old male suffering from type III hyperlipoproteinemia with xanthomatosis. Apo E3-Leiden focus in the E3 position. In contrast with normal apo E3, apo E3-Leiden is defective in binding to the low density lipoprotein (LDL) receptor and does not contain cysteine as evaluated by cysteamine treatment of very low density lipoprotein followed by isoelectric focusing and conventional protein staining and by amino acid analysis. On sodium dodecyl sulfate polyacrylamide gel electrophoresis, apo E3-Leiden displays an electrophoretic mobility intermediate to that of normal apo E3 and apo E2 (Arg158→Cys). The mother and four siblings of the proband also have apo E3-Leiden and hyperlipoproteinemia type III; three of them with xanthomatosis. Two siblings do not show apo E3-Leiden in their VLDL fraction and do not have hyperlipoproteinemia type III. In the VLDL fractions of all affected family members only the presence of apo E3-Leiden could be detected after cysteamine treatment and isoelectric focusing followed by conventional protein staining. However, isoelectric focusing of cysteaminetreated sera followed by immunoblotting, using anti-apo E antiserum as first antiserum, demonstrates the presence of low amounts of normal apo E3 in addition to apo E3-Leiden in serum of the affected family members. These results indicate that all affected family members are heterozygotes E3/E3-Leiden and suggest that in this family type III hyperlipoproteinemia is transmitted as a dominant trait.This publication has 35 references indexed in Scilit:
- New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.JCI Insight, 1984
- Apolipoprotein EBethesda Isolation and partial characterization of a variant of human apolipoprotein e isolated from very low density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- A new isoform of apolipoprotein E — Apo E-5 — Associated with hyperlipidemia and atherosclerosisAtherosclerosis, 1984
- Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patientEuropean Journal of Clinical Investigation, 1984
- Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.JCI Insight, 1983
- Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.JCI Insight, 1981
- Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modificationBiochemistry, 1981
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Isolation and Partial Characterization of an Arginine-Rich Apolipoprotein from Human Plasma Very-Low-Density Lipoproteins: Apolipoprotein EHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1975
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972